Clinical trialNCT06395441RecruitingPhase 3Interventional

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

SponsorMayo ClinicEnrollment160Malignant Solid Neoplasm

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase III trial compares the effect of Wisconsin ginseng (panax quinquefolius) to placebo in patients with cancer that suffer from significant fatigue. Fatigue is among the most challenging symptoms to manage in patients with cancer, both on or off active treatment. This symptom complex meaningfully contributes to psychosocial distress, healthcare costs, and it also interferes with the delivery of anticancer therapies. American ginseng (Western ginseng) appears to be a promising appearing agent for treating cancer related fatigue. Western ginseng may reduce cancer-related fatigue.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniel S. Childs, MD
Mayo Clinic in Rochester
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Mayo Clinic Health System in Albert Lea
Albert Lea, Minnesota, United States
Mina Hanna, MD
Recruiting
Sanford Joe Lueken Cancer Center
Bemidji, Minnesota, United States
Jarrett Failing, MD
Recruiting
Essentia Health Saint Joseph'S Medical Center
Brainerd, Minnesota, United States
Bret Friday, MD
Recruiting
Essentia Health Deer River Clinic
Deer River, Minnesota, United States
Bret Friday, MD
Recruiting
Essentia Health St. Mary'S Detroit Lakes Clinic
Detroit Lakes, Minnesota, United States
Bret Friday, MD
Recruiting
Essentia Health Cancer Center
Duluth, Minnesota, United States
Bret Friday, MD
Recruiting
Essentia Health Fosston
Fosston, Minnesota, United States
Bret 1 Friday, MD
Recruiting
Essentia Health Hibbing Clinic
Hibbing, Minnesota, United States
Bret Friday, MD
Recruiting
Mayo Clinic Health System-Mankato
Mankato, Minnesota, United States
Stephan Thome, MD
Recruiting
Mmcorc Centracare Monticello Cancer Center
Monticello, Minnesota, United States
Completed
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Daniel S. Childs, M.D.Stacy D. D'Andre, M.D.
Recruiting
Essentia Health Sandstone
Sandstone, Minnesota, United States
Bret Friday, MD
Recruiting
Sanford Thief River Falls Medical Center
Thief River Falls, Minnesota, United States
Amit Panwalkar, MD
Recruiting
Essentia Health Virginia Clinic
Virginia, Minnesota, United States
Bret Friday, MD
Recruiting
Sanford Worthington Medical Center
Worthington, Minnesota, United States
Jonathan Bleeker, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo Administration

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Aug 2024
Primary completion: 30 Nov 2026
Completion: 30 Nov 2026
Last update posted: 30 Mar 2026
Registered enrollment: 160
Registry id: NCT06395441

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.